Lack of Randomized Data to Compare Drugs Nivolumab + Ipilimumab showed high response rate Randomized Data to Compare 1 Drug to Another

Marwan Fakih, MD, explains Lack of Randomized Data to Compare Drugs Nivolumab + Ipilimumab showed high response rate Randomized Data to Compare 1 Drug to Another at the 2018 Oncology Summit in Huntington Beach, CA

Go to: http://www.moasc.org for more information